Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Bol. méd. Hosp. Infant. Méx ; 47(2): 100-2, feb. 1990.
Artigo em Espanhol | LILACS | ID: lil-93583

RESUMO

Se presenta el caso de una paciente femenina de un año tres meses de edad quien en forma accidental ingirió "Endrín helios" (insecticida organoclorado ciclodieno) sobreviviendo a este evento. Clínicamente presentó crisis convulsivas sin aparentes secuelas neurológicas o hepáticas. Se realiza una revisión de los mecanismo de intoxicación por este tóxico, así como de la literatura al respecto. Itoxicaciones; crisis convulsivas; endrín, raticidas,; insecticidas


Assuntos
Lactente , Humanos , Feminino , Intoxicação , Endrin/efeitos adversos , Inseticidas Organoclorados/efeitos adversos , México , Convulsões/etiologia , Convulsões/terapia
2.
Int Arch Occup Environ Health ; 56(2): 75-9, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4055072

RESUMO

Vital status and cause of death were assessed for 232 of a group of 233 workers engaged in the manufacturing and formulation of aldrin, dieldrin, endrin and (for a limited period) Telodrin. This group is part of the total exposed population of more than 1000 workers and was selected for follow up on account of the high exposures in the initial years of manufacturing and formulation and of the long exposure (mean 11 years) and observation (mean 24 years) periods. Total observed mortality was 25 versus 38 expected on the basis of the death statistics of the male Dutch population. Of the 9 cancer deaths, 3 were caused by lung cancer, while the remaining 6 were each of a different nature. Although in this group exposures have been high and exposure, as well as observation periods, were long enough for meaningful evaluation, this study revealed no indication of a specific carcinogenic activity of aldrin, dieldrin or endrin in manufacturing plant workers exposed to these products.


Assuntos
Aldrina/efeitos adversos , Dieldrin/efeitos adversos , Endrin/efeitos adversos , Doenças Profissionais/induzido quimicamente , Idoso , Carcinógenos , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Neoplasias/induzido quimicamente , Países Baixos , Doenças Profissionais/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA